By MAPS
MAPS has completed two observational studies of the long-term effects of ibogaine treatment on patients undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand.
Read on maps.org
CLEAR ALL
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
My first encounter with ketamine did not go well.
2
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
Amazonian healing traditions collide with Western medical sensibilities.
A chemically tweaked version of the psychedelic drug ibogaine appears to relieve depression and addiction symptoms without producing hallucinations or other dangerous side effects.
Using the powerful anti-addictive properties of ibogaine, patients are not only able to conquer drug addiction but also cure a wide variety of mental health issues including depression, anxiety disorders, and PTSD.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.